Discrepancies in Composition and Biological Effects of Different Formulations of Chondroitin Sulfate

Discrepancies in Composition and Biological Effects of Different Formulations of Chondroitin Sulfate

Osteoarthritis is a common, progressive joint disease, and treatments generally aim for symptomatic improvement. However, SYmptomatic Slow-Acting Drugs in Osteoarthritis (SYSADOAs) not only reduce joint pain, but slow structural disease progression. One such agent is chondroitin sulfate—a complex, h...

Full description

Bibliographic Details
Main Authors: Johanne Martel-Pelletier, Aina Farran, Eulàlia Montell, Josep Vergés, Jean-Pierre Pelletier
Format: Article
Language:English
Published: MDPI AG 2015-03-01
Series:Molecules
Subjects:
chondroitin sulfate
biological product
animal origin
purity
process
osteoarthritis
joint structure modification
SYSADOA
Online Access:http://www.mdpi.com/1420-3049/20/3/4277

Internet

http://www.mdpi.com/1420-3049/20/3/4277

Similar Items